丝素的治疗潜力评价 稳定了菲西丁对性结肠炎的治疗
Chunru Wang1, Yingjie Xiang1, Wenjie Ma1
1Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China.
丝素稳定型素 (SS/FT) 通过减少炎症和改善结肠健康,有效治疗性结肠炎. 这种新的复合物对治疗这种慢性炎症性肠道疾病充满希望.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种具有高复发率的慢性炎症性肠病.
- 天然植物化学物质具有治疗潜力,但溶解性和稳定性不佳.
- 菲塞 (FT) 是一种植物化学物质,由于水溶性差,其有效性有限.
研究的目的:
- 为了研究丝素-素复合物 (SS/FT) 对性结肠炎的治疗潜力.
- 为了解决fisetin在体内应用中的溶解性和稳定性问题.
- 为了评估SS/FT在硫酸诱导大肠炎模型中的疗效.
主要方法:
- 开发一种丝素-素复合物 (SS/FT),以增强素的特性.
- 在临床前的模型中使用硫酸德克斯来诱导性结肠炎.
- 评估SS/FT对体重,结肠长度,免疫反应和结肠组织病理学的影响.
- 对cGAS/STING信号通路激活的分析,以应对SS/FT治疗.
主要成果:
- 在大肠炎模型中,SS/FT有效缓解了体重减轻和结肠缩短.
- 该复合物显著减少了结肠组织病理性病变,并降低了免疫反应的调节.
- SS/FT治疗导致cGAS/STING信号激活的减少.
- 丝素成功地稳定了菲塞丁,改善了其对UC的治疗潜力.
结论:
- SS/FT在性结肠炎治疗中显示出显著的治疗潜力.
- 该复合物通过调节免疫反应和信号通路,有效地减轻UC诱导的损伤.
- SS/FT为治疗性结肠炎提供了一种有希望的,稳定的天然化合物方法.
更多相关视频
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Constipation-Predominant IBS
Drugs that Stabilize Microtubules
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
